J9259 Paclitaxel (American Regent) - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Paclitaxel (American Regent)

Brand Name:

Paclitaxel (American Regent)

Strength:

1mg

HCPCS:

J9259

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antimitotic Agent

Minor Drug Class:

Taxane

Oral (Y/N):

No

FDA Approval Year:

2023

FDA Discontinuation Year:

CMS Effective Date:

July 11, 2023

CMS Discontinuation Date:

Status:

In Use